FGF21 Is Associated with Cognitive Impairments in Non-Elderly Patients

By Maryna Mullerman ’20   Patients with metabolic syndrome (MetS), associated with cognitive decline, often express elevated levels of fibroblast growth factor 21 (FGF21), an endocrine hormone for metabolic regulation. Arintaya Phrommintikul and researchers from Chiang Mai University in Thailand investigated the link between FGF21 and cognitive decline in elderly and non-elderly patients. They hypothesized that FGF21 levels corresponded with cognitive performance in younger and … Continue reading FGF21 Is Associated with Cognitive Impairments in Non-Elderly Patients